ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0874

RNA-Binding Proteins That Are Highly Expressed and Enriched in Healthy Cartilage but Suppressed in Osteoarthritis

Hannah Swahn, Merissa Olmer and Martin K Lotz, Scripps Research Institute, La Jolla, CA

Meeting: ACR Convergence 2023

Keywords: cartilage, Genomics and Proteomics, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0859–0885) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: RNA-binding proteins (RBPs) have diverse and essential biological functions, but their role in cartilage health and disease is largely unknown. The objectives of this study were (i) map the global landscape of RBPs expressed and enriched in heathy cartilage and dysregulated in osteoarthritis (OA); (ii) prioritize RBPs for their potential role in cartilage and in OA pathogenesis and as therapeutic targets.

Methods: Our published bulk RNA-sequencing (RNA-seq) data of healthy and OA human cartilage, and a census of 1,542 RBPs were utilized to identify RBPs that are expressed in healthy cartilage and differentially expressed (DE) in OA. Next, our comparison of healthy cartilage RNA-seq data to 37 transcriptomes in the Genotype-Tissue Expression (GTEx) database was used to determine RBPs that are enriched in cartilage. Finally, expression of RBPs was analyzed in our single cell RNA-sequencing (scRNA-seq) data from healthy and OA human cartilage.

Results: We first investigated in an RNA-seq dataset of healthy human knee cartilage the expression patterns of genes encoding RBPs. Expression of RBPs was higher than nonRBPs, transcription factors (TFs) and long non-coding RNAs (lncRNAs) in healthy cartilage. We next asked which RBPs were specifically enriched in cartilage compared to 37 other issues in GTEx. This analysis revealed 313 cartilage-enriched genes, 11 of which were RBPs (Figure 1). In OA cartilage, 188 RBPs were DE, with a greater proportion downregulated (Figure 2). After identifying the DE RBPs, we investigated their protein associations using STRING. The 188 DE RBPs formed a highly dense protein-protein interaction network. We next investigated both the gene ontology programs and biological pathways associated with the up- and downregulated RBPs. Ribosome biogenesis was enriched in the upregulated RBPs, while splicing and transport were enriched in the downregulated. ChIP-X Enrichment Analysis 3 (ChEA3) was used to identify potential TFs that regulate the DE RBPs. Of the top 20 TFs, the MYC proto-oncogene (MYC) was predicted to regulate the largest number of upregulated RBPs at 42. Of the top 20 TFs, Activating Transcription Factor 1 (ATF1) was predicted to regulate the largest number of downregulated RBPs at 58. To identify a candidate RBP for further studies and as potential therapeutic targets, we investigated other parameters in addition to differential expression including: (i) the top 10% expressed RBPs in healthy cartilage and (ii) those that were cartilage-enriched according to GTEx. Intersecting these three criteria, we identified Tetrachlorodibenzodioxin (TCDD) Inducible Poly(ADP-Ribose) Polymerase (TIPARP) as a candidate RBP (Figure 3). TIPARP was downregulated in OA at both the gene expression and protein levels. scRNA-seq data revealed TIPARP was most significantly downregulated in the ‘pathogenic cluster’ as well as other fibrocytic clusters, suggesting a context-specific effect for TIPARP in chondrocyte function, which was not evident in the bulk RNA-seq data alone.

Conclusion: Our global analyses reveal expression patterns of RBPs in healthy and OA cartilage. We also identified TIPARP and other RBPs as novel mediators in OA pathogenesis and as potential therapeutic targets.

Supporting image 1

Figure 1. Heatmap showing average normalized counts of cartilage-enriched RBPs compared to all other GTEx tissues.

Supporting image 2

Figure 2. Volcano plot showing 188 DE RBPs. Blue indicates downregulation in OA cartilage compared to healthy, and red indicates upregulation. Gray indicates no significance. Bar chart showing proportion of downregulated (blue) vs upregulated (red) RBPs in OA cartilage. ****p<0.0001 by comparison of proportions test.

Supporting image 3

Figure 3. Venn diagram showing intersection of highly expressed (top 10%) RBPs in healthy cartilage, GTEx cartilage-enriched RBPs and DE RBPs in OA cartilage.


Disclosures: H. Swahn: None; M. Olmer: None; M. Lotz: None.

To cite this abstract in AMA style:

Swahn H, Olmer M, Lotz M. RNA-Binding Proteins That Are Highly Expressed and Enriched in Healthy Cartilage but Suppressed in Osteoarthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/rna-binding-proteins-that-are-highly-expressed-and-enriched-in-healthy-cartilage-but-suppressed-in-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rna-binding-proteins-that-are-highly-expressed-and-enriched-in-healthy-cartilage-but-suppressed-in-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology